¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"specimen interaction volume"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
effective circulating volume
À¯È¿¼øÈ¯¿ëÀû
end-diastolic volume
È®Àå±â¸»¿ëÀû
end-systolic volume
¼öÃà±â¸»¿ëÀû
flow volume curve
À¯·®¿ë·®°î¼±
forced expiratory volume
³ë·Â³¯¼ûÆóȰ·®, °Á¦È£±â·®
inspiratory reserve volume
µé¼û¿¹ºñ·®, ¿¹ºñÈí±â·®
minute volume
1. ºÐ´çÈ£Èí·® 2. ºÐ´ç¹ÚÃâ·®
mean corpuscular volume
Æò±ÕÀûÇ÷±¸¿ëÀû
mean platelet volume
Æò±ÕÇ÷¼ÒÆÇ¿ëÀû
plasma volume expander
Ç÷ÀåÁõ·®Á¦
pressure volume curve
¾Ð·Â¿ëÀû°î¼±
pressure volume relation
¾Ð·Â¿ëÀû°ü°è
packed cell volume
³óÃ༼Æ÷¿ëÀû, ÃæÀü¼¼Æ÷¿ëÀû
partial volume effect
ºÎºÐ¿ëÀûÈ¿°ú
residual volume
Àܱⷮ, ³²Àº°ø±â·®
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
specimen stability
°Ë»ç¹°¾ÈÁ¤¼º
type specimen
±âÁØÇ¥º»
urine specimen
¿ä°Ë»ç¹°
volume acquisition
¿ëÀûȹµæ
blood volume
Ç÷¾×·®
circulating blood volume
¼øÈ¯Ç÷¾×·®
clinical target volume
ÀÓ»óÇ¥ÀûüÀû
flow volume curve
À¯·®¿ë·®°î¼±
pressure volume curve
¾Ð·Â¿ëÀû°î¼±
volume conduction
º¼·ýÀüµµ
volume elasticity coefficient
¿ëÀûź·Â·ü
pressure volume diagram
¾Ð·Â¿ëÀû±×¸²Ç¥
volume dilatometer
ºÎÇÇÆØÃ¢°è, ¿ëÀûÆØÃ¢°è
effective blood volume
À¯È¿Ç÷¾×·®
effective circulating volume
À¯È¿¼øÈ¯¿ëÀû
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
MCV=ÊÝmean corpuscular volume
Æò±Õ ÀûÇ÷±¸¿ëÀû.
MPV => mean platelet volume
Æò±ÕÇ÷¼ÒÆÇ¿ëÀû
RV=£¾residual volume
Àü±â·®.
VT => tidal volume
ÀÏȸ È£Èí·®
Vd : volume of distribution
ºÐÆ÷¿ëÀû.
alveolar ventilation volume
ÆóÆ÷ȯ±â¿ëÀû
alveolar volume
ÆóÆ÷¿ëÀû
gross tumor volume, GTV
À°¾ÈÀûÁ¾¾çüÀû
high volume sampler
ÇÏÀ̺¼·ý»ùÇ÷¯.
inspiratory reserve volume
Èí½Ä(¼º)¿¹ºñ¿ëÀû(ýåãÓàõçãÝáé»îÝ), Èí±âÀܱⷮ( ¡íÑѨåÖ).
inspiratory triggering volume
Èí±âÀ¯¹ß·®.
phonatory air volume
¹ß¼º½Ã°ø±â·®(¡ãÁÍöѨåÖ).
planning target volume
°èȹ¿ë Ç¥ÀûºÎÇÇ
plasma expander =p. volume e.
´ë¿ëÇöóÁ<Ç÷Àå>, ÇöóÁ<Ç÷Àå(úìíì )>Áõ·®Á¦(¡ñòåÖð¥).
plasma volume
Ç÷Àå·®(úìíìåÖ).
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
additive interaction
»ó°¡(ßÓÊ¥)ÀÛ¿ë.
antigen antibody interaction
Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
antigen antibody interaction
Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
antigen antibody interaction
Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
antigen-antibody interaction
Ç׿ø-Ç×ü»óÈ£ÀÛ¿ë
binocular interaction
¾ç¾È»óÈ£ÀÛ¿ë
cell interaction
¼¼Æ÷»óÈ£ÀÛ¿ë
cellular interaction
¼¼Æ÷»óÈ£ÀÛ¿ë
dipolar interaction
½Ö±ØÀÚ»óÈ£ÀÛ¿ë
dipole dipole interaction
½Ö±ØÀÚ ½Ö±ØÀÚ »óÈ£ÀÛ¿ë
drug interaction
¾à¹° »óÈ£ÀÛ¿ë
drug interaction
¾à¹°»óÈ£ÀÛ¿ë.
drug interaction
¾à¹°»óÈ£ÀÛ¿ë(å·ÚªßÓû»íÂéÄ).
drugs,interaction
»óÈ£ÀÛ¿ë(ßÓû»íÂéÄ)
genetic interaction
À¯ÀüÀû »óÈ£ÀÛ¿ë
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½